Literature DB >> 15972959

Increased toll-like receptor 4 expression in thymus of myasthenic patients with thymitis and thymic involution.

Pia Bernasconi1, Massimo Barberis, Fulvio Baggi, Laura Passerini, Maria Cannone, Elisa Arnoldi, Lorenzo Novellino, Ferdinando Cornelio, Renato Mantegazza.   

Abstract

Thymic abnormalities are present in approximately 80% of myasthenia gravis (MG) patients, and the thymus seems to be the main site of autosensitization to the acetylcholine receptor. In view of findings that the innate immune system can generate an autoimmune response, we studied the expression of Toll-like receptors (TLRs) 2 to 5, key components of innate immunity signaling pathways, in 37 thymuses from patients with autoimmune MG. TLR4 mRNA levels were significantly greater in thymitis (hyperplasia with diffuse B-cell infiltration) and involuted thymus than in germinal center hyperplasia and thymoma. By immunohistochemistry and confocal microscopy, cells positive for TLR4 protein were rarely detected in thymoma. However, in thymitis TLR4 protein was mostly found on epitheliomorphic (cytokeratin-positive) cells located in close association with clusters of acetylcholine receptor-positive myoid cells in thymic medulla and also at the borders between cortical and medullary areas. B cells were never TLR4-positive. TLR4 protein was also present in remnant tissue of involuted thymus. This is the first finding of a possible link between innate immunity and MG. We speculate that in a subgroup of MG patients, an exogenous or endogenous danger signal may activate the innate immune system and give rise to TLR4-mediated mechanisms contributing to autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15972959      PMCID: PMC1603452          DOI: 10.1016/S0002-9440(10)62960-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  G S Gronseth; R J Barohn
Journal:  Neurology       Date:  2000-07-12       Impact factor: 9.910

Review 2.  Toll-like receptors: critical proteins linking innate and acquired immunity.

Authors:  S Akira; K Takeda; T Kaisho
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

3.  Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2.

Authors:  J da Silva Correia; K Soldau; U Christen; P S Tobias; R J Ulevitch
Journal:  J Biol Chem       Date:  2001-03-26       Impact factor: 5.157

4.  True epithelial hyperplasia in the thymus of early-onset myasthenia gravis patients: implications for immunopathogenesis.

Authors:  I Roxanis; K Micklem; N Willcox
Journal:  J Neuroimmunol       Date:  2001-01-01       Impact factor: 3.478

Review 5.  Mouse CD1-specific NK1 T cells: development, specificity, and function.

Authors:  A Bendelac; M N Rivera; S H Park; J H Roark
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

6.  Natural killer cells determine the outcome of B cell-mediated autoimmunity.

Authors:  F D Shi; H B Wang; H Li; S Hong; M Taniguchi; H Link; L Van Kaer; H G Ljunggren
Journal:  Nat Immunol       Date:  2000-09       Impact factor: 25.606

Review 7.  Toll-like receptor family and signalling pathway.

Authors:  M Muzio; N Polentarutti; D Bosisio; P P Manoj Kumar; A Mantovani
Journal:  Biochem Soc Trans       Date:  2000-10       Impact factor: 5.407

8.  Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.

Authors:  Elizabeth A Leadbetter; Ian R Rifkin; Andreas M Hohlbaum; Britte C Beaudette; Mark J Shlomchik; Ann Marshak-Rothstein
Journal:  Nature       Date:  2002-04-11       Impact factor: 49.962

9.  Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.

Authors:  Kol A Zarember; Paul J Godowski
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

Review 10.  Innate immunity and autoimmunity: from self-protection to self-destruction.

Authors:  F D Shi; H G Ljunggren; N Sarvetnick
Journal:  Trends Immunol       Date:  2001-02       Impact factor: 16.687

View more
  15 in total

1.  Identification of novel MicroRNA signatures linked to experimental autoimmune myasthenia gravis pathogenesis: down-regulated miR-145 promotes pathogenetic Th17 cell response.

Authors:  Jiao Wang; Shuangshuang Zheng; Ning Xin; Changxin Dou; Linlin Fu; Xiuying Zhang; Jing Chen; Yanyan Zhang; Deqin Geng; Chenghua Xiao; Guiyun Cui; Xia Shen; Yang Lu; Jinhua Wang; Ruiguo Dong; Yuehua Qiao; Yong Zhang
Journal:  J Neuroimmune Pharmacol       Date:  2013-09-17       Impact factor: 4.147

2.  Possible involvement of toll-like receptors in the pathogenesis of myasthenia gravis.

Authors:  Yu-Zhong Wang; Mei Yan; Fa-Fa Tian; Jun-Mei Zhang; Qun Liu; Huan Yang; Wen-Bin Zhou; Jing Li
Journal:  Inflammation       Date:  2013-02       Impact factor: 4.092

Review 3.  The impact of the gut microbiota on T cell ontogeny in the thymus.

Authors:  Roopa Hebbandi Nanjundappa; Channakeshava Sokke Umeshappa; Markus B Geuking
Journal:  Cell Mol Life Sci       Date:  2022-04-04       Impact factor: 9.261

4.  The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker.

Authors:  Rosaria Cammarota; Valentina Bertolini; Giuseppina Pennesi; Eraldo O Bucci; Ornella Gottardi; Cecilia Garlanda; Luigi Laghi; Massimo C Barberis; Fausto Sessa; Douglas M Noonan; Adriana Albini
Journal:  J Transl Med       Date:  2010-11-08       Impact factor: 5.531

Review 5.  Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.

Authors:  Marieke Robinet; Solène Maillard; Mélanie A Cron; Sonia Berrih-Aknin; Rozen Le Panse
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

6.  TIPE2 Play a Negative Role in TLR4-Mediated Autoimmune T Helper 17 Cell Responses in Patients with Myasthenia Gravis.

Authors:  Yong Zhang; Zhen Shao; Xiuying Zhang; Xiao Jia; Yan Xia; Yanyan Zhang; Ning Xin; Mingfeng Guo; Jing Chen; ShuangShuang Zheng; YuZhong Wang; Linlin Fu; Ruiguo Dong; Chenghua Xiao; Deqin Geng; Yonghai Liu
Journal:  J Neuroimmune Pharmacol       Date:  2015-10-24       Impact factor: 4.147

7.  Current and emerging therapies for the treatment of myasthenia gravis.

Authors:  Renato Mantegazza; Silvia Bonanno; Giorgia Camera; Carlo Antozzi
Journal:  Neuropsychiatr Dis Treat       Date:  2011-03-22       Impact factor: 2.570

8.  Inflammation and epstein-barr virus infection are common features of myasthenia gravis thymus: possible roles in pathogenesis.

Authors:  Paola Cavalcante; Lorenzo Maggi; Lara Colleoni; Rosa Caldara; Teresio Motta; Carmelo Giardina; Carlo Antozzi; Sonia Berrih-Aknin; Pia Bernasconi; Renato Mantegazza
Journal:  Autoimmune Dis       Date:  2011-09-26

9.  Autophagy, inflammation and innate immunity in inflammatory myopathies.

Authors:  Cristina Cappelletti; Barbara Galbardi; Dimos Kapetis; Gaetano Vattemi; Valeria Guglielmi; Paola Tonin; Franco Salerno; Lucia Morandi; Giuliano Tomelleri; Renato Mantegazza; Pia Bernasconi
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

10.  Increased Thymic Cell Turnover under Boron Stress May Bypass TLR3/4 Pathway in African Ostrich.

Authors:  Hai-bo Huang; Ke Xiao; Shun Lu; Ke-li Yang; Abdur Rahman Ansari; Haseeb Khaliq; Hui Song; Juming Zhong; Hua-zhen Liu; Ke-mei Peng
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.